Galectin Therapeutics Price Chart
Galectin Therapeutics Volume Chart
Galectin Therapeutics Market Segments
Regular Trading Hours
+0.05(+1.59%)
| Open | $3.15 |
|---|---|
| Close | $3.20 |
| Low | $3.15 |
| Low Change | 0.00 (0.00%) |
| High | $3.31 |
| High Change | +0.16 (+5.14%) |
| Range | $0.16 |
| Volume | 81.583K |
| Dollar Volume | $261.07K |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $3.18 |
|---|---|
| Close | $3.18 |
| Low | $3.18 |
| Low Change | 0.00 (0.00%) |
| High | $3.18 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 873 |
| Dollar Volume | $2.78K |
Regular Trading Hours Yesterday
+0.07(+2.08%)
| Open | $3.12 |
|---|---|
| Close | $3.19 |
| Low | $3.06 |
| Low Change | -0.06 (-1.92%) |
| High | $3.28 |
| High Change | +0.16 (+5.13%) |
| Range | $0.22 |
| Volume | 217.137K |
| Dollar Volume | $691.58K |
Premarket Yesterday
+0.01(+0.33%)
| Open | $3.06 |
|---|---|
| Close | $3.07 |
| Low | $3.06 |
| Low Change | 0.00 (0.00%) |
| High | $3.07 |
| High Change | +0.01 (+0.33%) |
| Range | $0.01 |
| Volume | 1.2K |
| Dollar Volume | $3.68K |
Galectin Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $3.10 |
|---|---|
| 10 Day Moving Average (SMA10) | $3.11 |
| 20 Day Moving Average (SMA20) | $3.06 |
| 50 Day Moving Average (SMA50) | $3.10 |
| 100 Day Moving Average (SMA100) | $4.26 |
| 200 Day Moving Average (SMA200) | $3.83 |
Galectin Therapeutics Statistics
| Average Volume (30 Days) | 326.28K |
|---|---|
| P/E Ratio (Current) | -5.33 |
| EPS (Current) | -$0.58 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 0.08 |
| Current Ratio | 0.09 |
| Quick Ratio | 0.09 |
| Debt to Equity | -0.98 |
| Enterprise Value | $309.97M |
| EV to EBITDA | -10.63 |
| EV to Sales | — |
| Price to Book | -1.59 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -2.91% |
| Return on Equity | 0.30% |
Galectin Therapeutics Stock Splits
There has been 1 stock split for Galectin Therapeutics (GALT). The reverse stock split occured on March 23, 2012 and reduced the outstanding shares at a ratio of 6:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 23, 2012 | Reverse | 6:1 |
Galectin Therapeutics Dividends
There have been no dividends for Galectin Therapeutics (GALT).